Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $73,716.

  • China Pharma Holdings' Other Working Capital Changes rose 105.34% to $178 in Q3 2025 from the same period last year, while for Sep 2025 it was $64,401, marking a year-over-year increase of 180.37%. This contributed to the annual value of $73,716 for FY2024, which is 117.42% up from last year.
  • Latest data reveals that China Pharma Holdings reported Other Working Capital Changes of $73,716 as of FY2024, which was up 117.42% from -$423,261 recorded in FY2023.
  • China Pharma Holdings' Other Working Capital Changes' 5-year high stood at $339,659 during FY2022, with a 5-year trough of -$520,414 in FY2021.
  • Its 3-year average for Other Working Capital Changes is -$3,295, with a median of $73,716 in 2024.
  • Per our database at Business Quant, China Pharma Holdings' Other Working Capital Changes surged by 474.07% in 2020 and then plummeted by 406.60% in 2021.
  • China Pharma Holdings' Other Working Capital Changes (Yearly) stood at $169,736 in 2020, then slumped by 406.60% to -$520,414 in 2021, then soared by 165.27% to $339,659 in 2022, then slumped by 224.61% to -$423,261 in 2023, then skyrocketed by 117.42% to $73,716 in 2024.